Sean Carrick - 31 Mar 2023 Form 4 Insider Report for Nascent Biotech Inc.

Role
President & CEO, Director, 10%+ Owner
Signature
/s/ Sean Carrick
Issuer symbol
NBIO on OTC
Transactions as of
31 Mar 2023
Net transactions value
+$70,020
Form type
4
Filing time
09 Jun 2023, 15:27:59 UTC
Previous filing
03 Jan 2023
Next filing
14 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBIO Common Stock Other $70,020 +1,167,000 +6.5% $0.0600* 19,233,607 31 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as part of the employment contract with the Company.